Actively Recruiting
Effects of Adding Quercetin or Alpha Lipoic Acid to Usual Care on Symptoms and Blood Markers in Iraqi Women With Polycystic Ovary Syndrome
Led by Al-Mustansiriyah University · Updated on 2025-09-19
150
Participants Needed
1
Research Sites
31 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study will investigate whether the addition of Quercetin or Alpha-Lipoic Acid (ALA) to standard metformin therapy can improve symptoms, hormone levels, metabolic health, and quality of life in women with polycystic ovary syndrome (PCOS). Over 3 months, participants will be randomly assigned to one of three groups: metformin alone, metformin plus Quercetin, or metformin plus ALA. Researchers will measure changes in hormones, blood sugar, cholesterol, and antioxidant markers, as well as quality of life and medication adherence. Physical measurements and side effects will also be recorded to assess safety and overall benefit.
CONDITIONS
Official Title
Effects of Adding Quercetin or Alpha Lipoic Acid to Usual Care on Symptoms and Blood Markers in Iraqi Women With Polycystic Ovary Syndrome
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women aged 18 to 40 years newly diagnosed with PCOS
- Presence of micro polycystic ovaries on ultrasound
- Irregular menstrual cycles with intervals longer than 35 days (oligomenorrhea)
- Clinical or biochemical signs of high male hormones such as acne or excess hair growth
- Normal prolactin (PRL) levels
You will not qualify if you...
- Presence of adrenal enzyme deficiency or other endocrine diseases including diabetes
- Other health conditions like hypertension, cardiovascular disease, or hormonal dysfunction
- Recent use of oral contraceptives, hormonal therapy, or anti-lipidemic drugs
- Pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mustansiriyah University/ College of Pharmacy
Baghdad, Karkh, Iraq, 00964
Actively Recruiting
Research Team
M
Mohammed Mahmood Mohammed, professor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here